STAMBP and colitis: Bettenworth et al. (2011) used an α-MSH C-terminus fragment tripeptide K(d)PT in their in vitro/in vivo IL10 deficient colitis mice models to note a reduced severity in inflammation and improved transepithelial electrical resistance after IFNγ and TNFα activation.